Similar articles

• [Generic medicines].

  Peláez de Loño J. Peláez de Loño J. Rev Enferm. 1999 Dec;22(12):836-43. Rev Enferm. 1999. PMID: 10797771 Spanish.
• Lowering the cost of prescription drugs.

  Jindal B. Jindal B. J La State Med Soc. 2003 Jan-Feb;155(1):51. J La State Med Soc. 2003. PMID: 12656276 No abstract available.
• Teva Pharmaceuticals v. Sandoz: availability of generic glatiramer acetate and the impact to patent litigation claim construction.

  Fogel LE, Ray CJ. Fogel LE, et al. Expert Opin Ther Pat. 2015 Jan;25(1):1-4. doi: 10.1517/13543776.2014.977866. Epub 2014 Nov 1. Expert Opin Ther Pat. 2015. PMID: 25363310
• The North American Free Trade Agreement's effect on pharmaceutical patents: a bitter pill to swallow or a therapeutic solution?

  Silbermann JM. Silbermann JM. J Contemp Health Law Policy. 1996 Spring;12(2):607-36. J Contemp Health Law Policy. 1996. PMID: 8666736 Review. No abstract available.
• The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.

  Openshaw MS. Openshaw MS. Nurs Econ. 2005 Nov-Dec;23(6):307-11, 279. Nurs Econ. 2005. PMID: 16459902 Review.